These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21843417)

  • 1. Predictors of repeated PSA testing among black and white men from the Maryland Cancer Survey, 2006.
    Zhu Y; Sorkin JD; Dwyer D; Groves C; Steinberger EK
    Prev Chronic Dis; 2011 Sep; 8(5):A114. PubMed ID: 21843417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
    Etzioni R; Berry KM; Legler JM; Shaw P
    Urology; 2002 Feb; 59(2):251-5. PubMed ID: 11834397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study.
    Moses KA; Zhao Z; Bi Y; Acquaye J; Holmes A; Blot WJ; Fowke JH
    Prostate Cancer Prostatic Dis; 2017 Dec; 20(4):424-429. PubMed ID: 28695916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
    Iyer HS; Stone BV; Roscoe C; Hsieh MC; Stroup AM; Wiggins CL; Schumacher FR; Gomez SL; Rebbeck TR; Trinh QD
    JAMA Netw Open; 2024 Jun; 7(6):e2414582. PubMed ID: 38833252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.
    Mariotto AB; Etzioni R; Krapcho M; Feuer EJ
    Cancer; 2007 May; 109(9):1877-86. PubMed ID: 17372918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
    JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer.
    Wolf MS; Knight SJ; Lyons EA; Durazo-Arvizu R; Pickard SA; Arseven A; Arozullah A; Colella K; Ray P; Bennett CL
    Urology; 2006 Jul; 68(1):89-93. PubMed ID: 16844451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age, race, and repeated prostate-specific antigen (PSA) test use in the National Health Interview Survey.
    Ross LE; Uhler RJ
    Ethn Dis; 2006; 16(1):244-7. PubMed ID: 16599378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of healthcare barriers with prostate-specific antigen screening among African-American and Afro-Caribbean men.
    Lee DJ; Consedine NS; Gonzalez JR; Spencer BA
    Urology; 2012 Sep; 80(3):556-63. PubMed ID: 22789295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.
    Ross LE; Berkowitz Z; Ekwueme DU
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):636-44. PubMed ID: 18349281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and prostate cancer screening among African-American and Caucasian men.
    Fowke JH; Signorello LB; Underwood W; Ukoli FA; Blot WJ
    Prostate; 2006 Sep; 66(13):1371-80. PubMed ID: 16752375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen as predictor of prostate cancer in black men and white men.
    Whittemore AS; Lele C; Friedman GD; Stamey T; Vogelman JH; Orentreich N
    J Natl Cancer Inst; 1995 Mar; 87(5):354-60. PubMed ID: 7531773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen screening among young men in the United States.
    Scales CD; Antonelli J; Curtis LH; Schulman KA; Moul JW
    Cancer; 2008 Sep; 113(6):1315-23. PubMed ID: 18696715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lifetime risk of developing prostate cancer in white and black men.
    Merrill RM; Weed DL; Feuer EJ
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):763-8. PubMed ID: 9332756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting Black Men to Undergo Prostate Cancer Screening: The Role of Social Capital.
    Dean LT; Subramanian SV; Williams DR; Armstrong K; Zubrinsky Charles C; Kawachi I
    Am J Mens Health; 2015 Sep; 9(5):385-96. PubMed ID: 25117538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
    Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
    J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific reference ranges for serum prostate-specific antigen in black men.
    Morgan TO; Jacobsen SJ; McCarthy WF; Jacobson DJ; McLeod DG; Moul JW
    N Engl J Med; 1996 Aug; 335(5):304-10. PubMed ID: 8663870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.
    Lacher DA; Thompson TD; Hughes JP; Saraiya M
    Adv Data; 2006 Dec; (379):1-12. PubMed ID: 17348177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.
    Espaldon R; Kirby KA; Fung KZ; Hoffman RM; Powell AA; Freedland SJ; Walter LC
    Urology; 2014 Mar; 83(3):599-605. PubMed ID: 24439009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in prostate cancer screening by family history.
    Drake BF; Lathan CS; Okechukwu CA; Bennett GG
    Ann Epidemiol; 2008 Jul; 18(7):579-83. PubMed ID: 18486487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.